The La Antigen Is Over-Expressed in Lung Cancer and Is a Selective Dead Cancer Cell Target for Radioimmunotherapy Using the La-Specific Antibody APOMAB®
EJNMMI Research - Germany
doi 10.1186/2191-219x-4-2
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Springer Science and Business Media LLC